Gastrointestinal Malignancies in 2020 and Beyond
Latest therapeutic developments in GI cancer treatment from the WCGI congress, and implications on individualized clinical decision-making. How will emerging data shape future treatment paradigms?
FACULTY CO-CHAIR
Gerald Prager, MD
Medical University of Vienna, Vienna, Austria
FACULTY CO-CHAIR
Howard Hochster, MD, FACP
Rutgers Cancer Institute, Houston, TX, US
Faculty Members
Chiara Cremolini, MD
Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy
Dirk Arnold, MD, PhD
University of Hamburg and Asklepios Tumor Center, Hamburg, Germany
Fotios Loupakis, MD, PhD
Veneto Institute of Oncology, Padua, Italy
Axel Grothey, MD
West Cancer Center, Germantown, TN, US
Julien Taieb, MD, PhD
Georges Pompidou European Hospital, Paris, France
Philip A. Philip, MD, PhD
Barbara Ann Karmanos Cancer Institute, Detroit, MI, US
Elizabeth C. Smyth, MD
Memorial Sloan Kettering Cancer Center, New York, NY, US
Jordi Bruix, MD, PhD
University of Barcelona, Barcelona, Spain
Juan Valle, MD, PhD
University of Manchester, Manchester, UK
Tanios S. Bekaii-Saab, MD
Mayo Clinic, Phoenix, AZ, US
Marc Peeters, MD, PhD
Antwerp University Hospital, Antwerp, Belgium
REPORT TOPICS INCLUDE
- Metastatic Colorectal Cancers
- Recent Insights and Future Approaches: Chemotherapy and Targeted Therapies
- Recent Insights and Future Approaches: Immunotherapy and Targeted Therapies
- Gastroesophageal Cancers
- Hepatocellular and Biliary Tract Cancers
- Biology-Guided Treatment of Locally Advanced/Metastatic Pancreatic Cancer
